NCT06061276
- Conditions
- Adenocarcinoma, Camrelizumab, Carcinoma, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
Clinical trial condition
Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
NCT06061276
NCT06581315
NCT06577272
NCT06041477
NCT04770207
NCT06248580
NCT06070636
NCT06519578